Lymphangioleiomyomatosis. Clinical course in 32 patients.

Amiodarone Pulmonary Toxicity: Recognition and Pathogenesis (Part I)

Background: Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease that primarily affects women. The purpose of these guidelines is to provide recommendations for the diagnosis and treatment of LAM.Methods: Systematic reviews were performed to summarize evidence pertinent to our questions. The evidence was summarized and discussed by a multidisciplinary panel. Evidence-based recommendations were then formulated, written, and graded using the Grading of Recommendations, Assessment, Development, and Evaluation approach.Results: After considering the panel’s confidence in the estimated effects, the balance of desirable (i.e., benefits) and undesirable (i.e., harms and burdens) consequences of treatment, patient values and preferences, cost, and feasibility, recommendations were formulated for or against specific interventions. These included recommendations for sirolimus treatment and vascular endothelial growth factor D testing and recommendations against doxycycline and hormonal therapy.Conclusions: ...

/pdf/official-american-thoracic-society-japanese-respiratory-2te98b8cyf.pdf

Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management

Lymphangioleiomyomatosis: A Review

Pulmonary Tuberous Sclerosis

Subacute pneumopathy during amiodarone therapy.

Pulmonary lymphangiomyomatosis associated with tuberous sclerosis. Treatment with tamoxifen and tetracycline-pleurodesis.

POSC295 Delay in Shock Wave Lithotripsy and Healthcare Utilization Among Patients with a Stent Placement and Stone Disease

___(II.. selectedrelmrts Subacute Pneumopathy During AmiodaroneTherapy

POSB294 Delay in Percutaneous Nephrolithotomy and Healthcare Utilization Among Patients with a Stent Placement and Stone Disease

Boris Eisner

Papers

Subacute pneumopathy during amiodarone therapy.

Pulmonary lymphangiomyomatosis associated with tuberous sclerosis. Treatment with tamoxifen and tetracycline-pleurodesis.

POSC295 Delay in Shock Wave Lithotripsy and Healthcare Utilization Among Patients with a Stent Placement and Stone Disease

___(II.. selectedrelmrts Subacute Pneumopathy During AmiodaroneTherapy

POSB294 Delay in Percutaneous Nephrolithotomy and Healthcare Utilization Among Patients with a Stent Placement and Stone Disease